• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化应激和血管内皮生长因子表达在翼状胬肉发病机制及手术切除后预防翼状胬肉复发中的作用。

Role of oxidative stress and vascular endothelial growth factor expression in pterygium pathogenesis and prevention of pterygium recurrence after surgical excision.

作者信息

Elgouhary Sameh Mohamed, Elmazar Hesham Fouad, Naguib Mariana Ibrahim, Bayomy Noha Rabie

机构信息

Department of Ophthalmology, Menoufia University, Shibin Elkom, Egypt.

Benha Ophthalmic Hospital, Benha, Egypt.

出版信息

Int Ophthalmol. 2020 Oct;40(10):2593-2606. doi: 10.1007/s10792-020-01440-2. Epub 2020 Jun 6.

DOI:10.1007/s10792-020-01440-2
PMID:32506294
Abstract

PURPOSE

To assess the roles of oxidative stress and vascular endothelial growth factor (VEGF) in pterygium pathogenesis and prevention of pterygium recurrence after surgical excision.

METHODS

Surgically removed pterygium tissue from 35 pterygium patients and normal conjunctival samples from 15 patients matched for age and sex (used as controls) constituted the study samples. The conjunctival samples were preserved at - 80 °C until analysis. Catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSH) and total antioxidant (TAO) enzymatic activity and the levels of nitric oxide (NO), malondialdehyde (MDA) and VEGF were studied in both groups. To evaluate the recurrence rate after surgical excision, the pterygium patients were further subdivided into three groups according to the adjuvant therapy used to prevent recurrence. Group 1 consisted of 10 patients who were treated with 0.2 mg mitomycin-c (MMC) for 2 min. Group 2 consisted of 12 patients treated with subconjunctival bevacizumab injection after surgical removal of the pterygium. Group 3 consisted of 13 patients who underwent combined treatment with 0.2 mg of MMC for 2 min and subconjunctival bevacizumab injection. The follow-up of patients in the three groups ranged from 7 to 15 months.

RESULTS

The activities of CAT, SOD, GSH and TAO were significantly lower in pterygium samples than in normal conjunctival samples (p < 0.0001 each). The levels of MDA (p = 0.046), NO (p < 0.0001) and VEGF (p < 0.0001) were significantly higher in pterygium patients than in controls. The lowest recurrence rate after surgical excision was that of the third group.

CONCLUSIONS

Oxidative stress and VEGF could play a role in the pathogenesis of pterygium as indicated by decreased antioxidant enzymatic activity and increased levels of VEGF in the pterygium tissue and the role of MMC and anti-VEGF therapy in decreasing the recurrence rate after surgical excision.

摘要

目的

评估氧化应激和血管内皮生长因子(VEGF)在翼状胬肉发病机制以及手术切除后预防翼状胬肉复发中的作用。

方法

35例翼状胬肉患者手术切除的翼状胬肉组织以及15例年龄和性别匹配的正常结膜样本(用作对照)构成研究样本。结膜样本保存在-80°C直至分析。研究了两组中过氧化氢酶(CAT)、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH)和总抗氧化剂(TAO)的酶活性以及一氧化氮(NO)、丙二醛(MDA)和VEGF的水平。为了评估手术切除后的复发率,根据用于预防复发的辅助治疗方法,将翼状胬肉患者进一步分为三组。第1组由10例用0.2mg丝裂霉素C(MMC)治疗2分钟的患者组成。第2组由12例在手术切除翼状胬肉后结膜下注射贝伐单抗治疗的患者组成。第3组由13例接受0.2mg MMC治疗2分钟并结膜下注射贝伐单抗联合治疗的患者组成。三组患者的随访时间为7至15个月。

结果

翼状胬肉样本中CAT、SOD、GSH和TAO的活性显著低于正常结膜样本(每项p<0.0001)。翼状胬肉患者中MDA(p=0.046)、NO(p<0.0001)和VEGF(p<0.0001)的水平显著高于对照组。手术切除后复发率最低的是第三组。

结论

翼状胬肉组织中抗氧化酶活性降低和VEGF水平升高表明氧化应激和VEGF可能在翼状胬肉发病机制中起作用,以及MMC和抗VEGF治疗在降低手术切除后复发率中的作用。

相似文献

1
Role of oxidative stress and vascular endothelial growth factor expression in pterygium pathogenesis and prevention of pterygium recurrence after surgical excision.氧化应激和血管内皮生长因子表达在翼状胬肉发病机制及手术切除后预防翼状胬肉复发中的作用。
Int Ophthalmol. 2020 Oct;40(10):2593-2606. doi: 10.1007/s10792-020-01440-2. Epub 2020 Jun 6.
2
Repeated bevacizumab injections versus mitomycin C in rotational conjunctival flap for prevention of pterygium recurrence.在旋转结膜瓣中,重复注射贝伐单抗与丝裂霉素C预防翼状胬肉复发的比较。
Indian J Ophthalmol. 2014 Apr;62(4):407-11. doi: 10.4103/0301-4738.120220.
3
A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients.一项评估结膜下注射贝伐单抗在印度患者原发性翼状胬肉手术中的作用的随机对照前瞻性研究。
Indian J Ophthalmol. 2015 Oct;63(10):779-84. doi: 10.4103/0301-4738.171508.
4
Anti-fibrotic, anti-VEGF or radiotherapy treatments as adjuvants for pterygium excision: a systematic review and network meta-analysis.抗纤维化、抗血管内皮生长因子或放射治疗作为翼状胬肉切除术辅助治疗的系统评价和网状Meta分析
BMC Ophthalmol. 2017 Nov 25;17(1):211. doi: 10.1186/s12886-017-0601-5.
5
Subconjunctival bevacizumab injection in the surgery of primary pterygium: comparison with intraoperative mitomycin-C.原发性翼状胬肉手术中结膜下注射贝伐单抗:与术中使用丝裂霉素C的比较
Bull Soc Belge Ophtalmol. 2013(322):7-12.
6
Conjunctival Autograft Combined With Either Preoperative Mitomycin C Injection or Intraoperative Local Mitomycin C Over the Medial Rectus Muscle Tendon in Primary Pterygium Surgery.在原发性翼状胬肉手术中,结膜自体移植联合术前丝裂霉素C注射或术中在内直肌肌腱上局部应用丝裂霉素C
Eye Contact Lens. 2018 Nov;44 Suppl 2:S192-S195. doi: 10.1097/ICL.0000000000000475.
7
Low-dose intraoperative mitomycin C as chemoadjuvant for pterygium surgery.低剂量术中丝裂霉素C作为翼状胬肉手术的化学辅助剂
Cornea. 2001 Jan;20(1):24-9. doi: 10.1097/00003226-200101000-00004.
8
Comparison of Two Techniques for the Treatment of Recurrent Pterygium: Amniotic Membrane vs Conjunctival Autograft Combined with Mitomycin C.两种复发性翼状胬肉治疗技术的比较:羊膜移植术与结膜自体移植联合丝裂霉素C
Semin Ophthalmol. 2015;30(5-6):321-7. doi: 10.3109/08820538.2013.874468. Epub 2014 Feb 7.
9
Conjunctival autografting combined with low-dose mitomycin C for prevention of primary pterygium recurrence.结膜自体移植联合低剂量丝裂霉素C预防原发性翼状胬肉复发
Am J Ophthalmol. 2006 Jun;141(6):1044-1050. doi: 10.1016/j.ajo.2005.12.028. Epub 2006 Mar 20.
10
Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up.结膜自体移植联合结膜下注射贝伐单抗治疗原发性翼状胬肉的随机对照试验:1年随访
Clin Exp Ophthalmol. 2014 Apr;42(3):235-41. doi: 10.1111/ceo.12140. Epub 2013 Jul 5.

引用本文的文献

1
The role of oxidative stress in the pathogenesis of ocular diseases: an overview.氧化应激在眼病发病机制中的作用:概述。
Mol Biol Rep. 2024 Mar 27;51(1):454. doi: 10.1007/s11033-024-09425-5.
2
Evaluating the application of argon laser on pterygium surgery: Report of 30 patients.评估氩激光在翼状胬肉手术中的应用:30例患者的报告。
Oman J Ophthalmol. 2023 Oct 18;16(3):478-481. doi: 10.4103/ojo.ojo_59_23. eCollection 2023 Sep-Dec.
3
Oxidative stress in the eye and its role in the pathophysiology of ocular diseases.眼睛中的氧化应激及其在眼部疾病病理生理学中的作用。

本文引用的文献

1
Current approaches and future directions in the management of pterygium.翼状胬肉治疗的当前方法与未来方向
Int J Ophthalmol. 2018 May 18;11(5):709-711. doi: 10.18240/ijo.2018.05.01. eCollection 2018.
2
Comparison among adjuvant treatments for primary pterygium: a network meta-analysis.原发性翼状胬肉辅助治疗方法的比较:网络荟萃分析。
Br J Ophthalmol. 2018 Jun;102(6):748-756. doi: 10.1136/bjophthalmol-2017-310288. Epub 2017 Nov 16.
3
Surgical techniques and adjuvants for the management of primary and recurrent pterygia.
Redox Biol. 2023 Dec;68:102967. doi: 10.1016/j.redox.2023.102967. Epub 2023 Nov 18.
4
Oxidative Stress in the Anterior Ocular Diseases: Diagnostic and Treatment.眼前部疾病中的氧化应激:诊断与治疗
Biomedicines. 2023 Jan 20;11(2):292. doi: 10.3390/biomedicines11020292.
5
Bibliometric analysis and mapping knowledge domain of pterygium: 2000-2019.翼状胬肉的文献计量分析与知识图谱构建:2000 - 2019年
Int J Ophthalmol. 2021 Jun 18;14(6):903-914. doi: 10.18240/ijo.2021.06.17. eCollection 2021.
原发性和复发性翼状胬肉的手术技术和辅助治疗。
J Cataract Refract Surg. 2017 Mar;43(3):405-419. doi: 10.1016/j.jcrs.2017.03.002.
4
Preoperative subconjunctival combined injection of bevacizumab and mitomycin C before the surgical excision of primary pterygium: clinical and histological results.原发性翼状胬肉手术切除前结膜下联合注射贝伐单抗和丝裂霉素C:临床及组织学结果
Clin Ophthalmol. 2017 Mar 10;11:493-501. doi: 10.2147/OPTH.S127700. eCollection 2017.
5
Low Recurrence Rate of Pterygium After Excision With Conjunctival Limbal Autograft: A Retrospective Study With Long-Term Follow-Up.自体结膜角膜缘移植切除翼状胬肉后的低复发率:一项长期随访的回顾性研究
Cornea. 2015 Dec;34(12):1569-72. doi: 10.1097/ICO.0000000000000597.
6
The expression of vascular endothelial growth factor in pterygium tissue of atopic patients.特应性患者翼状胬肉组织中血管内皮生长因子的表达。
Int Ophthalmol. 2014 Dec;34(6):1175-81. doi: 10.1007/s10792-013-9876-6. Epub 2014 Oct 26.
7
Intraoperative subconjunctival bevacizumab as an adjunctive treatment in primary pterygium: a preliminary report.术中结膜下注射贝伐单抗作为原发性翼状胬肉的辅助治疗:初步报告
Ophthalmic Surg Lasers Imaging. 2012 Nov-Dec;43(6):459-66. doi: 10.3928/15428877-20120802-02. Epub 2012 Aug 10.
8
Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial.切除原发性翼状胬肉后立即行结膜下贝伐单抗注射:首次临床试验。
Cornea. 2011 Nov;30(11):1219-22. doi: 10.1097/ICO.0b013e31820ca63f.
9
Treatment of pterygium.翼状胬肉的治疗。
Ann Afr Med. 2011 Jul-Sep;10(3):197-203. doi: 10.4103/1596-3519.84695.
10
Investigation of oxidative stress in pterygium tissue.翼状胬肉组织中氧化应激的研究。
Mol Vis. 2011 Feb 9;17:443-7.